BioNexus Gene Lab (BGLC) FCF Payout Ratio (2023 - 2024)
BioNexus Gene Lab (BGLC) posted FCF Payout Ratio of 0.0 for Q3 2024, up 50.46% sequentially from 0.0 in Q2 2024, and up 47.48% YoY from 0.0 in Q4 2023.
BioNexus Gene Lab (BGLC) FCF Payout Ratio (2023 - 2024) Analysis & Trends
BioNexus Gene Lab has reported FCF Payout Ratio for 2 years, with the latest figure at 0.0 in Q3 2024.
- Quarterly FCF Payout Ratio rose 47.48% year-over-year to 0.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 0.0 (changed N/A YoY) and the FY2023 annual result came in at 0.0, down 102.32% from the prior year.
- FCF Payout Ratio improved to 0.0 in Q3 2024 per BGLC's latest filing, from 0.0 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 0.0 in Q3 2024 and troughed at 0.05 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 225.36 Bn | 220.46 Bn | 4.43 Bn | 0.89 |
| 2 | Sherwin Williams | 84.52 Bn | 84.23 Bn | 3.34 Bn | 0.16 |
| 3 | Ecolab | 78.40 Bn | 73.27 Bn | 1.95 Bn | - |
| 4 | Air Products & Chemicals | 67.96 Bn | 66.98 Bn | 1.04 Bn | 1.30 |
| 5 | Ppg Industries | 25.28 Bn | 23.69 Bn | 1.81 Bn | 0.35 |
| 6 | Chemical & Mining Co Of Chile | 23.40 Bn | 19.53 Bn | 778.60 Mn | - |
| 7 | LyondellBasell Industries | 22.06 Bn | 19.43 Bn | 2.04 Bn | 0.46 |
| 8 | International Flavors & Fragrances | 21.43 Bn | 20.86 Bn | 853.00 Mn | 0.36 |
| 9 | DuPont de Nemours | 18.93 Bn | 17.19 Bn | 639.00 Mn | 0.25 |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -0.01 |